Fabry disease (Q40070): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed an Item
 
(7 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
A doença de Fabry é uma doença de depósito lisossomal multissistêmica progressiva, hereditária, caracterizada por manifestações neurológicas, cutâneas, renais, cardiovasculares, cócleo-vestibulares e cerebrovasculares.
description / endescription / en
 
Fabry disease (FD) is a progressive, inherited, multisystemic lysosomal storage disease characterised by specific neurological, cutaneous, renal, cardiovascular, cochleo-vestibular and cerebrovascular manifestations.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/66996647 / rank
 
Normal rank
Property / CURIE
 
CID11:5C56.01
Property / CURIE: CID11:5C56.01 / rank
 
Normal rank
Property / Canary Token
 
dki-india-5C56.01
Property / Canary Token: dki-india-5C56.01 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: E75.3 / rank
 
Normal rank

Latest revision as of 05:44, 13 August 2026

Fabry disease (FD) is a progressive, inherited, multisystemic lysosomal storage disease characterised by specific neurological, cutaneous, renal, cardiovascular, cochleo-vestibular and cerebrovascular manifestations.
Language Label Description Also known as
default for all languages
5C56.01
    English
    Fabry disease
    Fabry disease (FD) is a progressive, inherited, multisystemic lysosomal storage disease characterised by specific neurological, cutaneous, renal, cardiovascular, cochleo-vestibular and cerebrovascular manifestations.

      Statements

      CID11:5C56.01
      0 references
      dki-india-5C56.01
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references